Reuters logo
Swiss billionaire Wyss gets nearly 10 pct of Molecular Partners
2017年4月11日 / 早上8点22分 / 7 个月前

Swiss billionaire Wyss gets nearly 10 pct of Molecular Partners

ZURICH, April 11 (Reuters) - Swiss billionaire Hansjoerg Wyss has built a nearly 10 percent stake in biotech group Molecular Partners after share sales by Johnson & Johnson and other investors, the SIX Swiss Exchange said on Tuesday.

Wyss, who made a large share of his fortune by selling med-tech company Synthes Holding AG to J&J in 2012 for nearly $20 billion, now owns 9.85 percent of Molecular Partners, whose products include several prospective cancer and eye disease treatments with partners including Allergan.

In addition to J&J, Essex Woodlands Health Ventures and Index Ventures Associates IV Ltd have unloaded stakes this month.

Beyond ventures in Swiss medical companies, Wyss has given about $225 million to Harvard University and its Wyss Institute for Biologically Inspired Engineering. (Reporting by John Miller; Editing by Michael Shields)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below